Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Frontiers in Oncology
|
March 25, 2026
Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells
Hila Fishman, Hila M Ene, Einav Zeevi, et al.
International Journal of Molecular Sciences
|
November 26, 2022
Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model
Yiftah Barsheshet, Tali Voloshin, Boris Brant, et al.
Molecular Cancer Therapeutics
|
June 30, 2025
Cancer Cell Permeability Induced by Tumor Treating Fields (TTFields) as a Physical Approach to Improve Chemotherapy Uptake and Overcome Multidrug Resistance
Bella Koltun, Tali Voloshin, Cfir David, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 5, 2021
Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models
Helena Mumblat, Antonia Martinez-Conde, Ori Braten, et al.
Frontiers in Microbiology
|
December 14, 2023
Tumor Treating Fields (TTFields) demonstrate antiviral functions <i>in vitro</i>, and safety for application to COVID-19 patients in a pilot clinical study
Avraham Abutbul, Helena Mumblat, Yaara Porat, et al.
Cell Death Discovery
|
July 10, 2025
The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields)
Kerem Wainer-Katsir, Adi Haber, Hila Fishman, et al.
Cell Death & Disease
|
March 28, 2025
Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields)
Anat Klein-Goldberg, Tali Voloshin, Efrat Zemer Tov, et al.
International Journal of Cancer
|
February 27, 2026
Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab-paclitaxel
Tal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
Mono-allelic p.R37H Dehydrodolichyl Diphosphate Synthase variants lead to protein glycosylation defects, aberrant lipid profiles and interneuron scarcity in a novel mouse model of progressive epileptic encephalopathy
Afitz Da Silva, Samuel Boris Tene Tadoum, Irena J J Muffels, et al.
The Journal of Experimental Medicine
|
February 20, 2025
HMCN1 variants aggravate epidermolysis bullosa simplex phenotype
Shir Bergson, Ofer Sarig, Moshe Giladi, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Frontiers in Oncology
|
March 25, 2026
Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells
Hila Fishman, Hila M Ene, Einav Zeevi, et al.
International Journal of Molecular Sciences
|
November 26, 2022
Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model
Yiftah Barsheshet, Tali Voloshin, Boris Brant, et al.
Molecular Cancer Therapeutics
|
June 30, 2025
Cancer Cell Permeability Induced by Tumor Treating Fields (TTFields) as a Physical Approach to Improve Chemotherapy Uptake and Overcome Multidrug Resistance
Bella Koltun, Tali Voloshin, Cfir David, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 5, 2021
Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models
Helena Mumblat, Antonia Martinez-Conde, Ori Braten, et al.
Frontiers in Microbiology
|
December 14, 2023
Tumor Treating Fields (TTFields) demonstrate antiviral functions <i>in vitro</i>, and safety for application to COVID-19 patients in a pilot clinical study
Avraham Abutbul, Helena Mumblat, Yaara Porat, et al.
Cell Death Discovery
|
July 10, 2025
The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields)
Kerem Wainer-Katsir, Adi Haber, Hila Fishman, et al.
Cell Death & Disease
|
March 28, 2025
Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields)
Anat Klein-Goldberg, Tali Voloshin, Efrat Zemer Tov, et al.
International Journal of Cancer
|
February 27, 2026
Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab-paclitaxel
Tal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
Mono-allelic p.R37H Dehydrodolichyl Diphosphate Synthase variants lead to protein glycosylation defects, aberrant lipid profiles and interneuron scarcity in a novel mouse model of progressive epileptic encephalopathy
Afitz Da Silva, Samuel Boris Tene Tadoum, Irena J J Muffels, et al.
The Journal of Experimental Medicine
|
February 20, 2025
HMCN1 variants aggravate epidermolysis bullosa simplex phenotype
Shir Bergson, Ofer Sarig, Moshe Giladi, et al.
Page
of 10